Level Zero Health develops a biosensor platform for remote, continuous hormone monitoring. Its core product is a minimally invasive arm patch that uses DNA-based biosensors and microneedles to measure hormones such as estrogen, progesterone, cortisol, and testosterone in interstitial fluid. The patch attaches to the skin, accesses interstitial fluid with microneedles, and converts hormone levels into electronic signals sent to a connected system for real-time tracking integrated into clinical workflows. The company differentiates itself with continuous, real-time data from a wearable platform focused on women's health, validated at 98% accuracy in simulated clinical ranges, and pursuing FDA and CE approvals to enable IVF, menopause management, and testosterone replacement therapy applications. Its goal is to move hormone tracking from infrequent tests to continuous data streams to support better clinical decisions, with plans to expand into consumer and pharmaceutical markets.
Company Size
11-50
Company Stage
Seed
Total Funding
$6.9M
Headquarters
London, United Kingdom
Founded
2023
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?